References
- Epperson CN, Shanmugan S, Kim DR, et al. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology (Berl) 2015;232:3091–100
- NIH Consensus Statement. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consensus Statement 1998;16:1–37
- Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord 2010;2:241–55
- Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010;10:67
- Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 2007;20:386–92
- Faraone SV, Biederman J, Spencer T, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006;163:1720–9
- Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 2012;10:99
- Torgersen T, Gjervan B, Lensing MB, Rasmussen K. Optimal management of ADHD in older adults. Neuropsychiatr Dis Treat 2016;12:79–87
- Asherson P, Chen W, Craddock B, Taylor E. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 2007;190:4–5
- Skogli EW, Teicher MH, Andersen PN, Hovik KT, Øie M. ADHD in girls and boys – gender differences in co-existing symptoms and executive function measures. BMC Psychiatry 2013;13:298
- Haimov-Kochman R, Berger I. Cognitive functions of regularly cycling women may differ throughout the month, depending on sex hormone status; a possible explanation to conflicting results of studies of ADHD in females. Front Hum Neurosci 2014;8:191
- Lipnicki DM, Sachdev PS, Crawford J, et al. Sex differences could reflect discrepancies in the presence or extent of various risk and protective factors and/or prevalence of outcomes. PLoS One 2013;8:e65841
- Hesson J, Fowler K. Prevalence and correlates of self-reported ADD/ADHD in a large national sample of Canadian adults. J Atten Disord 2015 Mar 6; Epub ahead of print
- Epperson CN, Pittman B, Czarkowski KA, et al. Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women. Menopause 2011;18:542–8